As with all medical procedures, there are risks associated with TULSA-PRO®. Risks related to the technology are closely watched by the regulatory authorities to ensure patient risks are mitigated. Phase 1 results demonstrated a well-tolerated side effect profile with minor or no impact on urinary, erectile, and bowel function at 12 months1. Please consult with your doctor who will be able to outline all the risks associated with TULSA-PRO® .
There is also a potential risk of remaining prostate cancer after the procedure. Treatment with TULSA-PRO® does not prevent you from undergoing standard of care therapies for your prostate cancer in the future, such as radical prostatectomy (surgery) or radiation therapy.
1 Chin et al. European Urology. 2017